Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

Clinical trial NCT07225374 · RECRUITING

Trial details

NCT number: NCT07225374
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Upper Tract Urothelial Carcinoma

Start date: 2025-09-16
Primary completion: 2026-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.